Meeting
2021 Genitourinary Cancers Symposium
18F-DCFPyL PSMA PET imaging compared to conventional imaging in the detection of pelvic nodal metastases in patients with locally advanced or oligometastatic prostate cancer.
Authors
Ashanda Rosetta Patrice Esdaille
University of Wisconsin Health, Madison, WI
Ashanda Rosetta Patrice Esdaille , Edward Lawrence , Christos Kyriakopoulos , Brian Johnson , Alejandro Roldán-Alzate , Wei Huang , David J. Beebe , Hamid Emamekhoo , Shane Wells , Joshua Michael Lang , Steve Y. Cho , David Frazier Jarrard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Imaging
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 36)
DOI
10.1200/JCO.2021.39.6_suppl.36
Abstract #
36
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA-based PET as an imaging biomarker of androgen receptor signaling in high-risk localized and locally advanced prostate cancer (PCa).
First Author: Keara English
Poster
2024 ASCO Genitourinary Cancers Symposium
Total and anatomically contextualized quantitative 18F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression-free survival in patients with prostate cancer.
First Author: Hong Song
Poster
2024 ASCO Genitourinary Cancers Symposium
Performance of the F-PSMA 1007 PET/CT for high-risk prostate cancer staging: Experience from a Latin American reference center.
First Author: Sebastian Peña Rodriguez
Poster
2023 ASCO Annual Meeting
Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
First Author: Alberto Carretero-González